HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation.

AbstractBACKGROUND:
Transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) is a receptor used by B cell-activating factor of the TNF family and a proliferation-inducing ligand (APRIL) to induce isotype switching independently of CD40 and is mutated in patients with common variable immunodeficiency.
OBJECTIVE:
We sought to determine whether TACI and CD40 cooperate in inducing class switch recombination and immunoglobulin production.
METHODS:
Naive mouse B cells were stimulated with suboptimal concentrations of anti-CD40 plus IL-4 in the presence or absence of APRIL or anti-TACI. IgG(1) and IgE production was measured by means of ELISA. mRNA for Cgamma(1) and Cepsilon germ-line transcripts, activation-induced cytidine deaminase, and mature gamma(1) and epsilon transcripts were measured by means of RT-PCR. Plasmablasts were enumerated by using syndecan-1/CD138 staining. Interferon regulatory factor 4, B lymphocyte-induced maturation protein 1, and IL6 mRNA expression was measured by using quantitative PCR.
RESULTS:
TACI ligation enhanced IgG(1) and IgE secretion by naive murine B cells stimulated by anti-CD40 plus IL-4, with little effect on B-cell proliferation or class switch recombination. In contrast, TACI ligation of anti-CD40 plus IL-4-stimulated B cells induced a significant increase in syndecans-1/CD138-positive cells. TACI ligation caused a modest but significant increase in the expression of interferon regulatory factor 4, with no detectable change in B lymphocyte-induced maturation protein 1 expression.
CONCLUSION:
TACI and CD40 signaling converge to promote B-cell differentiation into plasmablasts.
CLINICAL IMPLICATIONS:
Our data suggest that TACI dysfunction could contribute to the impaired antibody response to T-dependent antigens in common variable immunodeficiency.
AuthorsEmanuela Castigli, Stephen A Wilson, Abdallah Elkhal, Esra Ozcan, Lilit Garibyan, Raif S Geha
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 120 Issue 4 Pg. 885-91 (Oct 2007) ISSN: 0091-6749 [Print] United States
PMID17689597 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • CD40 Antigens
  • Interferon Regulatory Factors
  • Tnfrsf13b protein, mouse
  • Tnfsf13 protein, mouse
  • Transmembrane Activator and CAML Interactor Protein
  • Tumor Necrosis Factor Ligand Superfamily Member 13
  • interferon regulatory factor-4
  • Interleukin-4
  • Immunoglobulin E
  • AICDA (activation-induced cytidine deaminase)
  • Cytidine Deaminase
Topics
  • Animals
  • B-Lymphocytes (physiology)
  • CD40 Antigens (physiology)
  • Cell Differentiation
  • Cytidine Deaminase (genetics)
  • Immunoglobulin E (biosynthesis)
  • Interferon Regulatory Factors (genetics)
  • Interleukin-4 (pharmacology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Plasma Cells (cytology)
  • Transmembrane Activator and CAML Interactor Protein (physiology)
  • Tumor Necrosis Factor Ligand Superfamily Member 13 (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: